Literature DB >> 9621865

Lung volume reduction surgery for emphysema: out on a limb without a NETT.

J P Utz1, R D Hubmayr, C Deschamps.   

Abstract

Lung volume reduction surgery (LVRS) has recently been rediscovered and offers the potential of improving the quality of life of patients with advanced emphysema. In this article, we discuss the historical and contemporary versions of LVRS. Although initial enthusiasm has been substantial, existing data seem insufficient to demonstrate the safety and efficacy of the procedure in comparison with conventional medical therapy. Fundamental questions remain regarding the long-term effects of an operation versus medical therapy, the optimal selection criteria, the best measures of efficacy, the mechanisms of improvement, the cost-effectiveness of the procedure, and the optimal surgical technique. Until such questions are answered, advising patients about the best management their emphysema will be difficult. The National Emphysema Treatment Trial will address many of these issues and should be embraced by both health-care providers and patients.

Entities:  

Mesh:

Year:  1998        PMID: 9621865     DOI: 10.4065/73.6.552

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

Review 1.  Recent advances: Respiratory medicine.

Authors:  H A Kerstjens; H J Groen; W van Der Bij
Journal:  BMJ       Date:  2001-12-08

Review 2.  Preoperative predictors of outcome following lung volume reduction surgery.

Authors:  F C Sciurba
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  Cost-effectiveness of lung volume reduction surgery.

Authors:  Scott D Ramsey; Sean D Sullivan; Robert M Kaplan
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

4.  Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  R S Goldstein; T R J Todd; G Guyatt; S Keshavjee; T E Dolmage; S van Rooy; B Krip; F Maltais; P LeBlanc; S Pakhale; T K Waddell
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

5.  Retinoic acid fails to reverse emphysema in adult mouse models.

Authors:  M Fujita; Q Ye; H Ouchi; N Nakashima; N Hamada; N Hagimoto; K Kuwano; R J Mason; Y Nakanishi
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

6.  Critical role of tumor necrosis factor receptor 1 in the pathogenesis of pulmonary emphysema in mice.

Authors:  Masaki Fujita; Hiroshi Ouchi; Satoshi Ikegame; Eiji Harada; Takemasa Matsumoto; Junji Uchino; Yoichi Nakanishi; Kentaro Watanabe
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.